HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human β2-microglobulin (β2m) double transgenic mice with disrupted mouse β2m

Journal of Clinical Investigation

Volumn 98, Issue 12, 1996, Pages 2746-2755

  Khare, Sanjay D ^a   Hansen, Julie ^a   Luthra, Harvinder S ^a   David, Chella S ^a  

^a MAYO CLINIC   (United States)

Author keywords

animal model; heavy chain; HLA B27; Reiter's disease; spondyloarthropathy

Indexed keywords

BETA 2 MICROGLOBULIN; HLA B27 ANTIGEN; MONOCLONAL ANTIBODY;

ALLELISM; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANKYLOSING SPONDYLITIS; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; CONTROLLED STUDY; GENE DISRUPTION; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030482194     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119100     Document Type: Article

References (41)

1. Brewerton, D.A., F.D. Hart, A. Nicholls, M. Caffrey, D.C. James, and R.D. Sturrock. 1973. Ankylosing spondylitis and HL-A 27. Lancet. i:904-907.
2. Burmester, G.R., A. Daser, T. Kamradt, A. Krause, N.A. Mitchison, J. Sieper, and N. Wolf. 1995. Immunology of reactive arthritides. Annu. Rev. Immunol. 13:229-250.
3. 2m: an animal model of HLA-B27 associated human disorders. Cell. 63:1099-1112.
4. Khare, S.D., H.S. Luthra, and C.S. David. 1995. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J. Exp. Med. 182:1153-1158.
5. Benjamin, R., and P. Parham. 1990. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today. 11:137-142.
6. Powis, S.J., E.V. Deverson, W.J. Coadwell, A. Ciruela, N.S. Huskisson, H. Smith, G.W. Butcher, and J.C. Howard. 1992. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature (Lond). 357:211-215.
7. Pearce, R.B., L. Trigler, E.K. Svaasand, and C.M. Peterson. 1993. Polymorphism in the mouse Tap-1 gene. Association with abnormal CD8+ T cell development in the nonobese nondiabetic mouse. J. Immunol. 151:5338-5347.
8. Maksymowych, W.P., A. Wessler, M. Schmitt-Egenolf, M. Suarez-Almazor, G. Ritzel, R.C. Von Borstel, F. Pazderka, and A.S. Russell. 1994. Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J. Rheumatol. 21:665-669.
9. Simmons, W.A., L.Y.W. Leong, N. Satumtira, G.W. Butcher, J.C. Howard, J.A. Richardson, C.A. Slaughter, R.E. Hammer, and J.D. Taurog. 1996. Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease. J. Immunol. 156:1661-1667.
10. Madden, D.R., J.C. Gorga, J.L. Strominger, and D.C. Wiley. 1992. The three dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 70:1035-1048.
11. Urban, R.G., R.M. Chicz, W.S. Lane, J.L. Strominger, A. Rehm, M.J. Kenter, F.G. UytdeHaag, H. Ploegh, B. Uchanska-Ziegler, and A. Ziegler. 1994. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. Natl. Acad. Sci. USA. 91:1534-1538.
12. Jardetzky, T.S., W.S Lane, R.A. Robinson, D.R. Madden, and D.C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature (Lond.). 353:326-329.
13. Fukazawa, T., E. Hermann, M. Edidin, J. Wen, F. Huang, H. Kellner, J. Floege, D. Farahmandian, K.M. Williams, and D.T.Y. Yu. 1994. The effect of mutant beta 2-microglobulins on the conformation of HLA-B27 detected by antibody and by CTL. J. Immunol. 153:3543-3550.
14. Scofield, R.H., W.L. Warren, G. Koelsch, and J.B. Harley. 1993. A hypothesis for the HLA-B27 dysregulation in spondyloarthopathy: contribution from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. Proc. Natl. Acad. Sci. USA. 90:9330-9334.
15. Scofield, R.H., B. Kurien, T. Gross, W.L. Warren, and J.B. Harley. 1995. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet (N. Am. Ed.). 345: 1542-1544.
16. Hermann, E., B. Fleischer, W.J. Mayet, T. Poralla, and K.H. Meyer zum Buschenfelde. 1989. Response of synovial fluid T cell clones to Yersinia enterocolitica antigens in patients with reactive Yersinia arthritis. Clin. Exp. Immunol. 75:365-370.
17. Viner, N.J., L.C. Bailey, P.P. Life, P.A. Bacon, and J.S.H. Gaston. 1991. Isolation of Yersinia-specific T-cell clones from the synovial membrane and synovial fluid of a patient with reactive arthritis. Arthritis Rheum. 34:1151-1157.
18. Schlaak, J., E. Hermann, M. Ringhoffer, P. Probst, H. Gallati, K.H. Meyer zum Buschenfelde, and B. Fleischer. 1992. Predominance of Th1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis. Eur. J. Immunol. 22:2771-2776.
19. Hermann, E., W.J. Mayet, H. Thomssen, J. Sieper, T. Poralla, K.H. Meyer zum Buschenfelde, and B. Fleischer. 1992. HLA-DP restricted Chlamydia trachomatis specific synovial fluid T cell clones in Chlamydia-induced Reiter's disease. J. Rheumatol. 19:1243-1246.
20. Hermann, E., DT. Yu, K.H. Meyer zum Buschenfelde, and B. Fleischer. 1993. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet (N. Am. Ed.). 342:646-650.
21. Hermann, E.M., R. Duchmann, E. May, B. Ackermann, and K.H. Meyer zum Buschenfelde. 1996. The T cell receptor (TCR) in HLA-B27-restricted T cell responses - an introduction. Clin. Rheumatol. 15(Suppl. 1):86-90.
22. Koller, B.H., P. Marrack, J. Kappler, and O. Smithies. 1990. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science (Wash. DC). 248:1227-1230.
23. Kievits, F., P. Ivanyi, P. Krimpenfort, A. Berns, and H.L. Ploegh. 1987. HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature (Lond.). 329:447-449.
24. Stam, N.J., H. Spits, and H.L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137:2299-2306.
25. Nabozny, G.H., M.J. Bull, J. Hanson, M.M. Griffiths, H.S. Luthra, and C.S. David. 1994. Collagen-induced arthritis in T cell receptor congenic B10.Q mice. J. Exp. Med. 180:517-524.
26. Altin, J.G., and E.B. Pagler. 1994. A one step procedure for biotinylation and chemical cross-linking of lymphocyte surface and intracellular membrane-associated molecules. Anal. Biochem. 224:382-389.
27. Wooley, P.H., H.S. Luthra, J.M. Stuart, and C.S. David. 1981. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp. Med. 154:688-700.
28. Khan, M.A. 1992. An overview of clinical spectrum and heterogeneity of spondyloarthropathies. Rheum. Dis. Clin. N. Am. 18:1-10.
29. Dekker-Saeys, B.J., S.G. Meuwissen, E.M. Van Den Berg-Loonen, W.H. De Haas, K.A Meijers, and G.N. Tytgat. 1978. Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease. Ann. Rheum. Dis. 37:36-41.
30. Keat, A. 1983. Reiter's syndrome and reactive arthritis in perspective. N. Engl. J. Med. 309:1606-1615.
31. Taurog, J.D., J.A. Richardson, J.T. Croft, W.A. Simmons, M. Zhou, J.L. Fernandez-Sueiro, E. Balish, and R.E. Hammer. 1994. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180:2359-2364.
32. Danliczyk, U.G., and T.L. Delovitch. 1994. Beta 2-microglobulin induces a conformational change in an MHC class I H chain that occurs intracellularly and is maintained at the cell surface. J. Immunol. 153:3533-3542.
33. Perarnau, B., C.A. Siegrist, A. Gillet, C. Vincent, S. Kimura, and F.A. Lemonnier. 1990. Beta 2-microglobulin restriction of antigen presentation. Nature (Lond.). 346:751-754.
34. 2-microglobulin. Hum. Immunol. 39:188-194.
35. Ribaudo, R.K., and D.H. Margulies. 1995. Polymorphism at position nine of the MHC class I heavy chain affects the stability of association with beta 2-microglobulin and presentation of a viral peptide. J. Immunol. 155:3481-3493.
36. Capps, G.G., B.E. Robinson, K.D. Lewis, and M.C. Zuniga. 1993. In vivo dimeric association of class I MHC heavy chains. J. Immunol. 151:159-169.
37. Zugel, U., B. Schoel, and S.H.E. Kaufmann. 1994. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone. J. Immunol. 153:4070-4079.
38. Lehmann-Grube, F., H. Dralle, O. Utermohlen, and J. Lohler. 1994. MHC class I molecule-restricted presentation of viral antigen in beta2-microglobulin-deficient mice. J. Immunol. 153:595-603.
39. Benjamin, R.J., J.A. Madrigal, and P. Parham. 1991. Peptide binding to empty HLA-B27 molecules of viable human cells. Nature (Lond.). 351:74-77.
40. De Bueger, M., A. Bakker, and E. Goulmy. 1992, Existence of mature human CD4+ T cells with genuine class I restriction. Eur. J. Immunol. 22:875-878.
41. Nonacs, R., C. Humborg, J.P. Tam, and R.M. Steinman. 1992. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific cytolytic T lymphocytes. J. Exp. Med. 176:519-529.